Long-term Oncologic Outcome Following Preoperative Combined Modality Therapy and Total Mesorectal Excision of Locally Advanced Rectal Cancer
José G. Guillem(Memorial Sloan Kettering Cancer Center), W. Douglas Wong(Memorial Sloan Kettering Cancer Center), Leonard B. Saltz(Roswell Park Comprehensive Cancer Center), Madhu Mazumdar(Icahn School of Medicine at Mount Sinai), David B. Chessin(Memorial Sloan Kettering Cancer Center), Jinru Shia(Memorial Sloan Kettering Cancer Center), Philip B. Paty(Memorial Sloan Kettering Cancer Center), Bruce D. Minsky(Harvard University), Warren E. Enker(Memorial Sloan Kettering Cancer Center), Martin R. Weiser(Memorial Sloan Kettering Cancer Center), Alfred M. Cohen(American Society of Clinical Oncology), David S. Klimstra(Memorial Sloan Kettering Cancer Center)
Cited by 388
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k